| dbo:abstract
|
- Wyeth v. Levine, 555 U.S. 555 (2009), is a United States Supreme Court case holding that Federal regulatory approval of a medication does not shield the manufacturer from liability under state law. (en)
|
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 11356 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:arguedate
|
- 0001-11-03 (xsd:gMonthDay)
|
| dbp:argueyear
| |
| dbp:case
| |
| dbp:concurrence
| |
| dbp:cornell
| |
| dbp:courtlistener
| |
| dbp:decidedate
|
- 0001-03-04 (xsd:gMonthDay)
|
| dbp:decideyear
| |
| dbp:dissent
| |
| dbp:docket
| |
| dbp:findlaw
| |
| dbp:fullname
|
- Wyeth, Petitioner v. Diana Levine (en)
|
| dbp:googlescholar
| |
| dbp:holding
|
- Federal law does not pre-empt Levine’s claim that Phenergan’s label did not contain an adequate warning about the IV-push method of administration. Supreme Court of Vermont affirmed. (en)
|
| dbp:joindissent
| |
| dbp:joinmajority
|
- Kennedy, Souter, Ginsburg, Breyer (en)
|
| dbp:justia
| |
| dbp:litigants
| |
| dbp:majority
| |
| dbp:oyez
| |
| dbp:parallelcitations
| |
| dbp:prior
| |
| dbp:uspage
| |
| dbp:usvol
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Wyeth v. Levine, 555 U.S. 555 (2009), is a United States Supreme Court case holding that Federal regulatory approval of a medication does not shield the manufacturer from liability under state law. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- (en)
- Wyeth, Petitioner v. Diana Levine (en)
|
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
